Drug intelligence / Profile preview

agave inulin

Development stage: Phase 3
Lead developer: Andrea Garcia Contreras
Modality: Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

Agave inulin is a prebiotic dietary fiber derived from the agave plant, primarily composed of fructose polymers. It functions by selectively stimulating the growth and activity of beneficial gut microorganisms, such as *Bifidobacterium* and *Lactobacillus* species, thereby modulating the intestinal microbiota. In clinical research led by Andrea Garcia Contreras at the New Civil Hospital of Guadalajara, agave inulin was evaluated for its efficacy in treating chronic constipation in children with cerebral palsy. The intervention demonstrated significant improvements in stool consistency, reduction in painful defecation, and decreased fecal mass retention. It is typically administered as a powder and is considered a naturally-derived dietary supplement rather than a traditional pharmaceutical drug.

Brand names: Inufib
Other names: agave inulin

Beyond the preview

Go deeper on agave inulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on agave inulin.

Explore the full profile